NEWS DETAIL

關於兒科研究計劃 (PIP) 的意見/決定:Jyseleca,馬來酸菲戈替尼,決定類型:PM:關於修改已商定 PIP 申請的決定,治療領域:肌肉骨骼和結締組織疾病,PIP 編號:EMA/PE/0000232302

Alfasigma S.p.A.

醫藥資訊

正文內容

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

文章相關商品

系統已根據文章標題、摘要和正文,自動匹配目前在售的強相關藥品。

常見問題

Which products are related to this article?

The system matched these relevant products from the article content: 盧修斯 非戈替尼 Filgotinib 線上購買.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp 微信 微信